Matches in Wikidata for { <http://www.wikidata.org/entity/Q83016516> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q83016516 description "artículu científicu espublizáu n'avientu de 2011" @default.
- Q83016516 description "scientific article published on 01 December 2011" @default.
- Q83016516 description "wetenschappelijk artikel" @default.
- Q83016516 description "наукова стаття, опублікована в грудні 2011" @default.
- Q83016516 name "Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up" @default.
- Q83016516 name "Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up" @default.
- Q83016516 type Item @default.
- Q83016516 label "Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up" @default.
- Q83016516 label "Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up" @default.
- Q83016516 prefLabel "Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up" @default.
- Q83016516 prefLabel "Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up" @default.
- Q83016516 P1433 Q83016516-341DD359-66F4-41B9-98FB-EFB75AAC2888 @default.
- Q83016516 P1476 Q83016516-7DE762D6-E526-4F07-B6FD-E35A9D714377 @default.
- Q83016516 P2093 Q83016516-176C55C1-2274-4741-B8C5-95638EA89FAE @default.
- Q83016516 P2093 Q83016516-447BD8EF-F452-4EDB-B589-9A96BABB5182 @default.
- Q83016516 P2093 Q83016516-CE76B44A-1E8A-4FCF-B767-129D1B8E30D0 @default.
- Q83016516 P2093 Q83016516-D7E30B61-C293-4CE5-8A51-CB4A42CE6555 @default.
- Q83016516 P2093 Q83016516-DF4099B8-092F-4926-BB4E-D49A3A3AAD5C @default.
- Q83016516 P2860 Q83016516-3E6963BF-A84B-40C4-93C9-426237EECB01 @default.
- Q83016516 P2860 Q83016516-D3C9DAB5-CA40-423C-814E-A871B8F4CF44 @default.
- Q83016516 P304 Q83016516-5513E888-EF13-4BD1-A2AD-E859B9598A72 @default.
- Q83016516 P31 Q83016516-A1C0779E-6ABA-4CED-8611-F447A25FB87E @default.
- Q83016516 P356 Q83016516-78F99062-152C-482F-AFB1-D6178295FC56 @default.
- Q83016516 P478 Q83016516-AC36D1F8-60E1-4BFA-9E7E-8C17411D21BD @default.
- Q83016516 P50 Q83016516-691ED451-BDAB-49AA-9556-414B443B80E1 @default.
- Q83016516 P577 Q83016516-9A70323C-5A5F-4418-936B-FC4DD08A5F26 @default.
- Q83016516 P698 Q83016516-63588493-7998-499C-AF16-CF65DA995AA0 @default.
- Q83016516 P921 Q83016516-467374B4-B6EF-464D-B3D5-DF74D44F1EE4 @default.
- Q83016516 P356 MDR470 @default.
- Q83016516 P698 22180398 @default.
- Q83016516 P1433 Q326122 @default.
- Q83016516 P1476 "Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up" @default.
- Q83016516 P2093 "C Pisano" @default.
- Q83016516 P2093 "D Leopardo" @default.
- Q83016516 P2093 "G S Bruni" @default.
- Q83016516 P2093 "L Cannella" @default.
- Q83016516 P2093 "S Pignata" @default.
- Q83016516 P2860 Q24600879 @default.
- Q83016516 P2860 Q29547625 @default.
- Q83016516 P304 "viii40-viii44" @default.
- Q83016516 P31 Q13442814 @default.
- Q83016516 P356 "10.1093/ANNONC/MDR470" @default.
- Q83016516 P478 "22 Suppl 8" @default.
- Q83016516 P50 Q56920378 @default.
- Q83016516 P577 "2011-12-01T00:00:00Z" @default.
- Q83016516 P698 "22180398" @default.
- Q83016516 P921 Q172341 @default.